Researchers present a new therapeutic tool capable of inhibiting the proliferation of the SARS-CoV-2 virus that causes COVID-19. The results open up new perspectives in the fight against this ...

While severe COVID-19 has typically been viewed as a result of an inflammatory “cytokine storm,” in which the immune response ...

Researchers at Kumamoto University have discovered a monoclonal antibody capable of neutralizing a wide range of SARS-CoV-2 ...

III-21," a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer in adult patients with pulmonary sequelae of COVID-19.

Researchers at The Jackson Laboratory and Trudeau Institute have identified the first mouse strain that is susceptible to ...

Pneumonia is a lung infection that causes inflammation ... pneumoniae Fungi from the zygomycete fungi family Viruses like SARS-CoV-2, the virus that causes COVID-19 Diagnosing pneumonia—whether ...

In the hamster model, it cleared both authentic wild-type SARS-CoV-2 and the omicron variant, thus alleviating viral pneumonia. To approach the genetic and epigenetic features of human lung cells ...

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have recently developed a ...

Sunshine Biopharma (SBFM) has developed an orally active protease inhibitor with dose-dependent antiviral activity in mice infected with SARS ...